Considering our findings, we believe that ATP1A2 and/or ARID3A play important roles in AAA initiation and progression, which broadens our understanding of the pathogenesis of AAA, and provides valuable insights for the future AAA therapeutic research. The gene discussed is ATP1A2; the disease is triple-A syndrome.